Charles Sternberg, Associate Editor04.29.22
NuVasive Inc. has surpassed a milestone of more than 100 peer-reviewed publications of the Precice System (Precice) for conditions related to limb lengthening and reconstruction from NuVasive Specialized Orthopedics (NSO).
The Precice System is an intramedullary nail that once implanted, utilizes an External Remote Controller (ERC) to non-invasively lengthen the limb. Precice is used to treat long bone abnormalities resulting from congenital bone conditions, oncology, or trauma.
"This significant milestone further supports the benefits that Precice offers orthopedic surgeons and their patients," said Dr. Stuart Green, orthopedic surgeon at UC Irvine School of Medicine. "First introduced in 2011, Precice has been used to successfully overcome limb length deficiencies in thousands of patients around the world with less pain and fewer complications than previously thought possible. The publications demonstrate the important role the implant plays in modern limb reconstruction—helping establish Precice as today's standard of care."
Following the first publication in 2014 in Clinical Orthopaedics and Related Research,1 more than 100 peer-reviewed publications have been authored in countries including the United States, Germany, and South Africa. Precice has been researched in dozens of journals including The Journal of Bone and Joint Surgery, Journal of Orthopaedic Trauma, Journal of the American Academy of Orthopaedic Surgeons, and The Journal of Surgical Orthopaedic Advances.
"With approximately 15,000 procedures in more than 45 countries, today's announcement is yet another significant milestone for Precice," said Pete Ligotti, general manager of NSO. "We remain committed to providing novel technology in underserved markets to help deliver better outcomes for surgeons—and most importantly for patients."
Reference:
1 Kirane Y, Fragomen A, Rozbruch S, et al. Precision of the PRECICE internal bone lengthening nail. Clinical Orthopaedics and Related Research: 2014, Dec;472(12):3869-78. doi: 10.1007/s11999-014-3575-0.
The Precice System is an intramedullary nail that once implanted, utilizes an External Remote Controller (ERC) to non-invasively lengthen the limb. Precice is used to treat long bone abnormalities resulting from congenital bone conditions, oncology, or trauma.
"This significant milestone further supports the benefits that Precice offers orthopedic surgeons and their patients," said Dr. Stuart Green, orthopedic surgeon at UC Irvine School of Medicine. "First introduced in 2011, Precice has been used to successfully overcome limb length deficiencies in thousands of patients around the world with less pain and fewer complications than previously thought possible. The publications demonstrate the important role the implant plays in modern limb reconstruction—helping establish Precice as today's standard of care."
Following the first publication in 2014 in Clinical Orthopaedics and Related Research,1 more than 100 peer-reviewed publications have been authored in countries including the United States, Germany, and South Africa. Precice has been researched in dozens of journals including The Journal of Bone and Joint Surgery, Journal of Orthopaedic Trauma, Journal of the American Academy of Orthopaedic Surgeons, and The Journal of Surgical Orthopaedic Advances.
"With approximately 15,000 procedures in more than 45 countries, today's announcement is yet another significant milestone for Precice," said Pete Ligotti, general manager of NSO. "We remain committed to providing novel technology in underserved markets to help deliver better outcomes for surgeons—and most importantly for patients."
Reference:
1 Kirane Y, Fragomen A, Rozbruch S, et al. Precision of the PRECICE internal bone lengthening nail. Clinical Orthopaedics and Related Research: 2014, Dec;472(12):3869-78. doi: 10.1007/s11999-014-3575-0.